DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Yoo C, Hwang JY, Kim JE. et al.
A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer.

Br J Cancer 2009;
101: 1658-1663

Download Bibliographical Data

Search in:
Access: